SUSMED,Inc. (TYO:4263)

Japan · Delayed Price · Currency is JPY

405.00

-6.00 (-1.46%)

Oct 6, 2026, 3:30 PM JST

Market Cap	6.91B -53.1%
Revenue (ttm)	497.00M +7.6%
Net Income	-382.00M
EPS	-22.67
Shares Out	16.81M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	61,100
Open	407.00
Previous Close	411.00
Day's Range	404.00 - 412.00
52-Week Range	392.00 - 1,231.00
Beta	1.14
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 6, 2026

About SUSMED,Inc.

SUSMED,Inc. develops and sells therapeutic applications in Japan. It operates through DTx product business, and DTx platform business segments. The company develops smartphone based digital therapeutics applications for diseases with insomnia, breast cancer, and kidney disease. It also develops and sells development platform for therapeutic apps and clinical trial systems. In addition, the company offers medical data analysis and consulting services. The company was incorporated in 2015 and is headquartered in Tokyo, Japan. [Read more]

Industry Biotechnology

Sector Healthcare

Founded 2015

Employees 43

Stock Exchange Tokyo Stock Exchange

Ticker Symbol 4263

Full Company Profile

Financial Performance

In fiscal year 2026, SUSMED,Inc.'s revenue was 497.00 million, an increase of 7.58% compared to the previous year's 462.00 million. Losses were -382.00 million, 28.2% more than in 2025.

Financial Statements